Tag:
ev3
Latest Headlines
Latest Headlines
Shareholders seek to block ev3 sale
ev3 ( NASDAQ:EVVV ) and its directors are facing several shareholder lawsuits designed to block the sale of the company to Covidien ( NYSE:COV ). The companies announced earlier this month that Covidien
Covidien buys ev3 for $2.6B
Covidien ( NYSE:COV ) has agreed to buy ev3 (NASDAQ:EVVV) for $22.50 per share in cash, for a total of $2.6 billion in an effort to expand its presence in the vascular market. The acquisition will add
